Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Net Margin (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Net Margin for 6 consecutive years, with 7.63% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 35.0% year-over-year to 7.63%, compared with a TTM value of 5.69% through Dec 2025, up 60.0%, and an annual FY2025 reading of 5.69%, up 60.0% over the prior year.
  • Net Margin was 7.63% for Q4 2025 at Viemed Healthcare, up from 5.01% in the prior quarter.
  • Across five years, Net Margin topped out at 12.79% in Q4 2021 and bottomed at 2.69% in Q2 2024.
  • Average Net Margin over 5 years is 5.63%, with a median of 5.59% recorded in 2021.
  • The sharpest move saw Net Margin tumbled -3958bps in 2021, then surged 296bps in 2023.
  • Year by year, Net Margin stood at 12.79% in 2021, then plummeted by -49bps to 6.5% in 2022, then rose by 5bps to 6.85% in 2023, then rose by 6bps to 7.29% in 2024, then increased by 5bps to 7.63% in 2025.
  • Business Quant data shows Net Margin for VMD at 7.63% in Q4 2025, 5.01% in Q3 2025, and 5.15% in Q2 2025.